ABBVIE INC (ABBV) Stock News
NYSE:ABBV - New York Stock Exchange, Inc. - US00287Y1091 - Common Stock - Currency: USD
ABBV Latest News, Press Relases and Analysis
What's going on in today's session: S&P500 movers
Stay informed about the performance of the S&P500 index in the middle of the day on Wednesday. Uncover the top gainers and losers in today's session for valuable insights.
These S&P500 stocks are gapping in today's session
Let's have a look at the S&P500 gap up and gap down stocks in today's session.
Is AbbVie Inc. (ABBV) the Best Pharma Stock to Buy for Long Term Growth?
We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best pharma stocks to buy for long term growth. U.S. Pharma Turns to China for Drug Deals With big American pharmaceutical […]
A Congress Member Sold Up To $120K In AbbVie Stock: Here's What You Need To Know
Mentions: AMZN
Is AbbVie Inc. (ABBV) the Best Large-Cap Value Stock to Buy as the Recession Hits?
We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best large-cap value stocks to buy as the recession hits. Goldman Sachs highlighted that equities around the world traded in and […]
Mentions: GS
AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: MRK
Shareholders that lost money on Cerevel Therapeutics Holdings, Inc.(ABBV) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. ("Cerevel Therapeutics Holdings, Inc." or the "Company") (NYSE:...
Brookfield Renewable Corporation (BEPC): Among the Best Utility Stocks to Buy According to Analysts
We recently published a list of 13 Best Utility Stocks to Buy According to Analysts. In this article, we are going to take a look at where Brookfield Renewable Corporation (NYSE:BEPC) stands against other best utility stocks to buy according to analysts. Utility stocks represent companies primarily engaged in providing electricity, natural gas, and water […]
AbbVie Inc. (ABBV): Among the Innovative Healthcare Stocks to Watch in 2025
In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023. In 2023, the healthcare industry made up 17.6% of the US economy, an increase of 17.4% from 2022. The growth of Medicare and private […]
ABBV LAWSUIT ALERT: The Gross Law Firm Notifies Cerevel Therapeutics Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
/PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. (NYSE: ABBV). Shareholders who purchased...
Is Exxon Mobil (XOM) Among The Top Goldman Sachs Value Stocks?
We recently published a list of Goldman Sachs Value Stocks: Top 12 Stock Picks. In this article, we are going to take a look at where Exxon Mobil Corporation (NYSE:XOM) stands against other Goldman Sachs value stocks to invest in. As we recently discussed in another article, growth stocks are massively overvalued and trading at […]
AbbVie Inc. (ABBV): One of the Best Dividend Monarchs to Invest in Now
We recently published a list of the 10 Best Dividend Monarchs to Invest in Now. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best dividend monarchs. Dividend-focused investors are generally well-acquainted with terms like Dividend Aristocrats and Dividend Kings, but many may not be aware […]
Unpacking Q4 Earnings: AbbVie (NYSE:ABBV) In The Context Of Other Therapeutics Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q4, starting with AbbVie (NYSE:ABBV).
AbbVie Inc. (ABBV): One of the High Growth Forever Dividend Stocks to Invest In
We recently published a list of the 10 High Growth Forever Dividend Stocks to Invest In. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other high growth forever dividend stocks. Dividend stocks have trailed the broader market over the past two years, largely due to investors favoring […]
The Zacks Analyst Blog Merck and AbbVie
Merck and AbbVie are included in this Analyst Blog.
Mentions: MRK
Is Invesco Large Cap Value ETF (PWV) a Strong ETF Right Now?
Smart Beta ETF report for PWV
ABBV vs. MRK: Which Drug Giant is a Better Buy Now?
Both ABBV and MRK are leading pharmaceutical companies with strong portfolios in oncology and immunology.
Is AbbVie Inc. (ABBV) the Best Stock for 15 Years?
We recently published a list of Long-Term Stock Portfolio: 15 Best Stocks for 15 Years. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best stocks for 15 years. Russell Investments believes that 3 features are defining the market outlook for 2025. These include the elevated level […]
Here’s Why Clearbridge Growth Strategy Sold AbbVie (ABBV)
ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. First quarter of 2025 witnessed sharp equities sell off due the shift out of mega caps. There was a relative outperformance of mid cap growth stocks over large and small […]
S&P, Dow Jones Pharma Names Rattled — Again — On Trump's Tariffs Whiplash
Here's why the 90-day tariffs delay doesn't help pharmaceutical companies.
3 Biopharmaceutical Stocks Bucking the Sell-Off
Three biopharma companies may appeal to investors looking for firms that have not been rocked by tariff-inspired turbulence.
The Last Time the Stock Market Started a Year This Badly Was 2022. Is Another Crash Coming?
Why The Walt Disney Company (DIS) is Among the Best Cruise Stocks to Buy According to Hedge Funds
We recently published a list of 12 Best Cruise Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where The Walt Disney Company (NYSE:DIS) stands against other best cruise stocks to buy according to hedge funds. Overview of the Cruise Line Industry The cruise industry is […]
Dow Jones, S&P 500 Pharma Names Slammed As New Trump Tariffs Target Drug Imports
Big pharmaceutical names plowed lower Wednesday after Trump on Tuesday said that tariffs would take aim at drug imports.
Stay updated with the S&P500 stocks that are on the move in today's pre-market session.
Before the opening bell on Wednesday, let's take a glimpse of the US markets and explore the S&P500 top gainers and losers in today's pre-market session.
AbbVie Announces European Commission Approval of RINVOQ® (upadacitinib) for the Treatment of Adults with Giant Cell Arteritis
RINVOQ is the first and only oral Janus kinase (JAK) inhibitor approved in the European Union (EU) to treat adult patients with giant cell arteritis (GCA) The...